These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34405873)

  • 1. Prevalence and predictors of long-acting reversible contraceptive use among sexually active women in 26 sub-Saharan African countries.
    Bolarinwa OA; Nwagbara UI; Okyere J; Ahinkorah BO; Seidu AA; Ameyaw EK; Igharo V
    Int Health; 2022 Sep; 14(5):492-500. PubMed ID: 34405873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and factors associated with the use of long-acting reversible and permanent contraceptive methods among women who desire no more children in high fertility countries in sub-saharan Africa.
    Bolarinwa OA; Afaya A; Ajayi KV; Ojo A; Alawode OA
    BMC Public Health; 2022 Nov; 22(1):2141. PubMed ID: 36414944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of contraceptive continuation among women in sub-Saharan Africa.
    Budu E; Okyere J; Osei MD; Seidu AA; Ahinkorah BO
    BMC Womens Health; 2023 Aug; 23(1):447. PubMed ID: 37620922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's sexual empowerment and utilization of long-acting reversible contraceptives in Ghana: evidence from the 2014 demographic and health survey.
    Adde KS; Appiah EA; Glozah FN; Tabong PT
    BMC Womens Health; 2023 Aug; 23(1):421. PubMed ID: 37559088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social context of contraceptive use transition among sexually active women in Zambia (1992-2018): A decomposition analysis.
    Phiri M; Odimegwu C; Adewoyin Y
    PLoS One; 2024; 19(4):e0300506. PubMed ID: 38625959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding barriers to using long-acting reversible contraceptives (LARCs) in primary care: a qualitative evidence synthesis.
    Linton E; Mawson R; Hodges V; Mitchell CA
    BMJ Sex Reprod Health; 2023 Oct; 49(4):282-292. PubMed ID: 36810206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between knowledge and use of contraceptive among women of reproductive age in sub-Saharan Africa.
    Donkoh IE; Okyere J; Seidu AA; Ahinkorah BO; Aboagye RG; Yaya S
    Health Sci Rep; 2024 May; 7(5):e2028. PubMed ID: 38736479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between history of hormonal contraceptive use and anaemia status among women in sub-Saharan Africa: A large population-based study.
    Aboagye RG; Okyere J; Seidu AA; Ahinkorah BO; Budu E; Yaya S
    PLoS One; 2023; 18(6):e0286392. PubMed ID: 37315029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends, patterns and determinants of long-acting reversible methods of contraception among women in sub-Saharan Africa.
    Adedini SA; Omisakin OA; Somefun OD
    PLoS One; 2019; 14(6):e0217574. PubMed ID: 31163050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and factors influencing long-acting reversible contraceptives use among women of reproductive age in Nigeria.
    Bolarinwa OA; Olagunju OS
    Gates Open Res; 2019; 3():7. PubMed ID: 32875280
    [No Abstract]   [Full Text] [Related]  

  • 11. Perceptions of indigenous ugandan men on the use of long acting reversible contraceptives (LARCs) by rural women.
    Kibonire RA; Mphuthi DD
    Contracept Reprod Med; 2023 Oct; 8(1):50. PubMed ID: 37845682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with long-acting reversible contraceptives usage among sexually active adolescent girls and young women in Zimbabwe.
    Chipako I; Singhal S; Hollingsworth B
    PLOS Glob Public Health; 2024; 4(8):e0003551. PubMed ID: 39163319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inequality gaps in modern contraceptive use and associated factors among women of reproductive age in Nigeria between 2003 and 2018.
    Bolarinwa OA
    BMC Womens Health; 2024 Jun; 24(1):317. PubMed ID: 38824536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of postpartum long-acting reversible contraceptives in the extended postpartum period in Shashago district, Central Ethiopia: a cross-sectional study conducted in the community.
    Eristu T; Mekis A; Abdo RA
    Contracept Reprod Med; 2024 May; 9(1):21. PubMed ID: 38730446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postpartum long-acting reversible contraceptives use in sub-Saharan Africa. Evidence from recent demographic and health surveys data.
    Asmamaw DB; Belachew TB; Fetene SM; Addis B; Amare T; Kidie AA; Endawkie A; Zegeye AF; Tamir TT; Wubante SM; Fentie EA; Negash WD
    PLoS One; 2023; 18(10):e0291571. PubMed ID: 37812616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of access to long-acting reversible contraception removal among women in Burkina Faso.
    Sokol NA; Sawadogo N; Bullington BW; Tumlinson K; Langer A; Soura A; Zabre P; Sie A; Johnson JA; Senderowicz L
    Contraception; 2024 Jan; 129():110302. PubMed ID: 37802461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent, long-acting and short-acting reversible contraceptive methods use among women in Bangladesh: an analysis of Bangladesh Demographic and Health Survey 2017-2018 data.
    Sharif AB; Hasan MT; Naziat MH; Zerin T; Kundu S
    BMJ Open; 2023 Jul; 13(7):e073469. PubMed ID: 37451714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial distribution and multilevel analysis of factors associated with long-acting reversible contraceptive use among sexually active women of reproductive age in Nigeria.
    Bolarinwa OA; Ajayi KV; Okeke SR; Hailegebreal S; Odimegwu C
    Arch Public Health; 2023 Jun; 81(1):99. PubMed ID: 37269016
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.